*3.5. Clinical-Pathological Features in Thyroid Cancer Patients with CONUT Score <3 (Group 1) and* ≥*3 (Group 2)*

According to the cut-off obtained by ROC analysis, the study population was divided into two groups: Group 1 (CONUT score <3) and Group 2 (CONUT score ≥3). No significant differences between the two groups regarding all clinical-pathological data collected (gender, age at beginning of treatment, time-lapse between cancer diagnosis and treatment, time-lapse between appearance of metastasis and treatment, tumor histotype, numbers of anatomical site involved, rate of bone metastasis, type of TKI, BMI, and ECOG PS) were observed in Group 1 compared to Group 2 (Table S2).
